| Project/Area Number |
07670924
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Pediatrics
|
|---|
| Research Institution | Kurume University |
|---|
Principal Investigator |
KIMURA Akihiko Kurume University, School of Medicine, Research Associates, 医学部, 助手 (00211201)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
INOUE Toshiro Kurume University, School of Medicine, Research Associates, 医学部, 助手 (00246638)
TOHMA Masahiko Health Sciences University of Hokkido, Faculty of Pharmaceutical Sciences, Profe, 薬学部・薬品分析科, 教授 (30001043)
|
|---|
| Project Period (FY) |
1995 – 1997
|
| Project Status |
Completed (Fiscal Year 1997)
|
| Budget Amount *help |
¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 1997: ¥300,000 (Direct Cost: ¥300,000)
Fiscal Year 1996: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 1995: ¥400,000 (Direct Cost: ¥400,000)
|
|---|
| Keywords | unsaturated ketonic bile acid / inborn error of bile acid metabolism / biliary atresia |
|---|
| Research Abstract |
Normal values of urinary DELTA^4-3-oxo-bile acids were established in the present from neonates to adults. Activity of 3-oxo-DELTA^4-steroid 5beta-reductase (5beta-reductase) increased immediately after birth, and thereafter the urinary DELTA^4-3-oxo-bile acids gradually decreased until 3 months of age. However, after 1 year of age we again detected small amounts of DELTA^4-3-oxo-bile acids in the urine, DELTA^4-3-oxo-bile acids produced in the intestine by bacterial flora.
The percentage of DELTA^4-3-oxo-bile acids in total bile acids (TBAs) in urine of biliary atresia significantly exceeded that of neonatal cholestasis or healthy controls (p<0.05). However, biliary atresia could not be distinguished from idiopathic neonatal hepatitis based on the percentage of DELTA^4-3-oxo-bile acids in TBAs in urine.
In this study, moreover, analysis of DELTA^4-3-oxo-bile acids in patients with 5beta-reductase, fulminant hepatie failure, and cirrhosis showcd that these patients exhibited a higher percentage of 7alpha-hydroxy-3-oxochol-4-en-24-oic acid and 3-oxochola-4,6-dien-24-oic acid in TBAs than 7alpha, 12alpha-dihydroxy-3-oxochol-4-en-24-oic acid and 12alpha-hydroxy-3-oxochola-4,6-dien-24-oic acid. These patients were positively correlated with poor prognosis. This finding suggests that a reduction in 5beta-reductase activity due to severe liver damage leads to reduction in 12alpha-hydroxylase.
We reported the first Japanese patient with 5beta-reductase deficiency during this study. It will very important to determine whether this disease should be defined as primary or secondary 5beta-reductase deficiency.
In conclusion, to determine the profile of unusual urinary bile acids, such as DELTA^4-3-oxo-bile acids, at an early stage of liver disease is important to define prognosis and/or treatment. We also think that analysis of urinary DELTA^4-3-oxo-bile acids is very useful to identify inborn errors in bile acid synthesis.
|
